Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients
NCT04682548
·
clinicaltrials.gov ↗
COMPLETED
Status
920
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Covid19
Sponsor
NYU Langone Health